참고문헌
- Murtaugh MP, Foss DL. Inflammatory cytokines and antigen presenting cell activation. Vet Immunol Immunopathol. 87: 109-121 (2002) https://doi.org/10.1016/S0165-2427(02)00042-9
- Caulfield JJ, Fernandez MH, Sousa AR, Lane SJ, Lee TH, Hawrylowicz CM. Regulation of major histocompatibility complex class II antigens on human alveolar macrophages by granulocyte-macrophage colony-stimulating factor in the presence of glucocorticoids. Immunology 98: 104-110 (1999) https://doi.org/10.1046/j.1365-2567.1999.00862.x
- Stonehouse TJ, Woodhead VE, Herridge PS, Ashrafian H, George M, Chain BM, Katz DR. Molecular characterization of U937-dependent T-cell co-stimulation. Immunology 96: 35-47 (1999) https://doi.org/10.1046/j.1365-2567.1999.00670.x
- Woods ML, Shimizu Y. Signaling networks regulating beta1 integrin-mediated adhesion of T lymphocytes to extracellular matrix. J Leukoc Biol. 69: 874-880 (2001)
- Van Waes C. Cell adhesion and regulatory molecules involved in tumor formation, hemostasis, and wound healing. Head Neck 17: 140-147 (1995) https://doi.org/10.1002/hed.2880170212
- Yusuf-Makagiansar H, Anderson ME, Yakovleva TV, Murray JS, Siahaan TJ. Inhibition of LFA-1/ICAM-1 and VLA-4/ VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Med Res Rev. 22: 146-167 (2002) https://doi.org/10.1002/med.10001
- Yun TK, Lee YS, Lee YH, Kim SI, Yun HY. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci. 16 Suppl: S6-18 (2001)
- Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin. 29: 1109-1118 (2008) https://doi.org/10.1111/j.1745-7254.2008.00869.x
- Kim BH, Lee YG, Park TY, Kim HB, Rhee MH, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway. Planta Med. 75: 321-326 (2009) https://doi.org/10.1055/s-0028-1112218
- Kim YS, Kim DS, Kim SI. Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2. Int J Biochem Cell Biol. 30: 327-338 (1998) https://doi.org/10.1016/S1357-2725(97)00141-6
- Wang YZ, Chen J, Chu SF, Wang YS, Wang XY, Chen NH, Zhang JT. Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's metabolites ginsenoside Rh1 and protopanaxatriol. J Pharmacol Sci. 109: 504-510 (2009) https://doi.org/10.1254/jphs.08060FP
- Samukawa K, Suzuki Y, Ohkubo N, Aoto M, Sakanaka M, Mitsuda N. Protective effect of ginsenosides Rg(2) and Rh(1) on oxidation-induced impairment of erythrocyte membrane properties. Biorheology 45: 689-700 (2008)
- Shin YW, Bae EA, Kim SS, Lee YC, Lee BY, Kim DH. The effects of ginsenoside Re and its metabolite, ginsenoside Rh1, on 12-O-tetradecanoylphorbol 13-acetate- and oxazoloneinduced mouse dermatitis models. Planta Med. 72: 376-378 (2006) https://doi.org/10.1055/s-2005-916217
- Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol. 133: 113-120 (2004) https://doi.org/10.1159/000076383
- Cho JY, Fox DA, Horejsi V, Sagawa K, Skubitz KM, Katz DR, Chain B. The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation. Blood 98: 374-382 (2001) https://doi.org/10.1182/blood.V98.2.374
- Larrucea S, Gonzalez-Rubio C, Cambronero R, Ballou B, Bonay P, Lopez-Granados E, Bouvet P, Fontan G, Fresno M, Lopez-Trascasa M. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem. 273: 31718-31725 (1998) https://doi.org/10.1074/jbc.273.48.31718
- Cho JY, Katz DR, Chain BM. Staurosporine induces rapid homotypic intercellular adhesion of U937 cells via multiple kinase activation. Br J Pharmacol. 140: 269-276 (2003) https://doi.org/10.1038/sj.bjp.0705436
- Cho JY, Chain BM, Vives J, Horejsi V, Katz DR. Regulation of CD43-induced U937 homotypic aggregation. Exp Cell Res. 290: 155-167 (2003) https://doi.org/10.1016/S0014-4827(03)00322-7
- Cho JY, Kim AR, Joo HG, Kim BH, Rhee MH, Yoo ES, Katz DR, Chain BM, Jung JH. Cynaropicrin, a sesquiterpene lactone, as a new strong regulator of CD29 and CD98 functions. Biochem Biophys Res Commun. 313: 954-961 (2004) https://doi.org/10.1016/j.bbrc.2003.12.026
- Cordes N, Park CC. beta1 integrin as a molecular therapeutic target. Int J Radiat Biol. 83: 753-760 (2007) https://doi.org/10.1080/09553000701639694
- Mettouchi A, Meneguzzi G. Distinct roles of beta1 integrins during angiogenesis. Eur J Cell Biol. 85: 243-247 (2006) https://doi.org/10.1016/j.ejcb.2005.09.010
- Matsumoto M, Shigeta A, Miyasaka M, Hirata T. CD43 plays both antiadhesive and proadhesive roles in neutrophil rolling in a context-dependent manner. J Immunol. 181: 3628-3635 (2008)
- Cho JY. Chloroquine, an anti-malarial agent, acts as a novel regulator of beta 1-integrin-mediated cell-cell adhesion. Biol Pharm Bull. 31: 726-730 (2008) https://doi.org/10.1248/bpb.31.726
- Deane JA, Hickey MJ. Molecular mechanisms of leukocyte trafficking in T-cell-mediated skin inflammation: insights from intravital imaging. Expert Rev Mol Med. 11: e25 (2009) https://doi.org/10.1017/S146239940900115X